Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
Kezar Life Sciences Total Long Term Debt (Quarterly) : 0.00 for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 6.653M |
| June 30, 2025 | 8.265M |
| March 31, 2025 | 10.44M |
| December 31, 2024 | 12.65M |
| September 30, 2024 | 13.52M |
| June 30, 2024 | 14.35M |
| March 31, 2024 | 15.15M |
| December 31, 2023 | 15.92M |
| September 30, 2023 | 16.66M |
| June 30, 2023 | 17.36M |
| March 31, 2023 | 18.05M |
| December 31, 2022 | 18.70M |
| September 30, 2022 | 11.99M |
| June 30, 2022 | 12.28M |
| March 31, 2022 | 12.57M |
| December 31, 2021 | 12.84M |
| September 30, 2021 | 3.536M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.842M |
| March 31, 2021 | 4.139M |
| December 31, 2020 | 4.422M |
| September 30, 2020 | 4.694M |
| June 30, 2020 | 4.96M |
| March 31, 2020 | 5.219M |
| December 31, 2019 | 5.464M |
| September 30, 2019 | 5.699M |
| June 30, 2019 | 5.929M |
| March 31, 2019 | 6.153M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| NovelStem International Corp. | 1.620M |
| Brainstorm Cell Therapeutics, Inc. | 0.00 |
| Summit Therapeutics, Inc. | 16.83M |
| Protara Therapeutics, Inc. | 1.463M |
| Clene, Inc. | 21.53M |